For DSS results, TPD52L2 was a risk factor in ACC, BLCA, BRCA, HNSC, KIRC, LGG, LIHC, LUSC, MESO, PRAD, and THCA (Figure 5B). Here, TPD52L2 is linked to adrenal cortex carcinoma.